VR Logo

Onconova Therapeutics Inc. (ONTX) download report


Healthcare | Biotechnology & Pharma Research

Onconova Therapeutics Inc. (ONTX) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer.

IPO Date: 25-Jul-2013

CEO, Pres & Director: Dr. Steven M. Fruchtman M.D.

Chief Financial Officer: Mr. Mark Patrick Guerin CPA

Listing: NASDAQ: ONTX

Country: United States

Headquarters: Newtown, PA

Website: https://www.onconova.com

Key Facts

Market cap: $27.79 Mln

Revenue (TTM): $0.11 Mln

Earnings (TTM): $-15.57 Mln

Cash: $50.77 Mln

Total Debt: $0.00 Mln

Insider's Holding: 0.54%

Liquidity: Low

52 Week range: $1.00 - 6.86

Shares outstanding: 20,895,600

10 Years Aggregate:

  • CFO: $-274.36 Mln
  • EBITDA: $-297.62 Mln
  • Net Profit: $-307.27 Mln

Stock Performance

Time Period Onconova Therapeutics (ONTX) S&P BSE Sensex S&P Small-Cap 600
YTD-49.02-9.18-19.12
1 month13.04-4.78-8.39
3 months-29.35-9.66-14.02
1 Year-81.240.81-17.54
3 Years-68.7910.335.95
5 Years-69.4211.345.78
10 Years--11.749.79
As on 01-Jul-2022
Year Onconova Therapeutics (ONTX) S&P Small-Cap 600 S&P BSE Sensex
2021-63.5025.2721.99
202021.629.5715.75
2019-81.8520.8614.38
2018-90.50-9.705.87
2017-33.9211.7327.91
2016-76.2824.741.95
2015-70.92-3.36-5.03